The table below shows KalVista Pharmaceuticals, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q2 2025
Q1 2025
Q2 2024
Q2 2023
Q2 2022
Operating cash flow
-$14.46M
-$54.50M
-$47.57M
-$40.22M
-$26.73M
-$22.74M
Capital expenditure
$121.00K
$290.00K
$288.00K
$21.00K
$6.00K
$920.00K
Investing cash flow
-$901.00K
$21.26M
-$3.72M
$37.16M
$19.61M
$30.04M
Dividends paid
-
-
-
-
KALV operating cash flow (10-K history)
KalVista Pharmaceuticals, Inc. reported operating cash flow of -$152.91M for fiscal year 2025. That is down 71.4% from -$89.23M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$13.16M (FY 2016) to -$152.91M. Figures come from the company's audited annual reports as filed with the SEC.